Leihong S. Deng

No. 1 Minde Road
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking.

Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking.

Journal: Scientific reports
Published: July 28, 2023

Ru-Based Organometallic Agents Bearing Phenyl Hydroxide: Synthesis and Antibacterial Mechanism Study against Staphylococcus aureus.

Ru-Based Organometallic Agents Bearing Phenyl Hydroxide: Synthesis and Antibacterial Mechanism Study against Staphylococcus aureus.

Journal: ChemMedChem
Published: June 13, 2023

RAB14 promotes epithelial-mesenchymal transition in bladder cancer through autophagy‑dependent AKT signaling pathway.

RAB14 promotes epithelial-mesenchymal transition in bladder cancer through autophagy‑dependent AKT signaling pathway.

Journal: Cell death discovery
Published: May 26, 2023

The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression.

The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression.

Journal: Translational oncology
Published: February 24, 2023

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.

Journal: Frontiers in oncology
Published: December 04, 2022

Properties of flavonoids in the treatment of bladder cancer (Review).

Properties of flavonoids in the treatment of bladder cancer (Review).

Journal: Experimental and therapeutic medicine
Published: June 09, 2022

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.

Journal: Journal of clinical laboratory analysis
Published: May 17, 2022

A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer.

A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer.

Journal: BMC cancer
Published: December 30, 2021

A Novel Neobladder-Urethral Drag-and-Bond Anastomosis Technique During Laparoscopic Radical Cystectomy for Ileal Orthotopic Neobladder: Surgical Technique and Initial Research.

A Novel Neobladder-Urethral Drag-and-Bond Anastomosis Technique During Laparoscopic Radical Cystectomy for Ileal Orthotopic Neobladder: Surgical Technique and Initial Research.

Journal: Cancer management and research
Published: November 08, 2020

Corrigendum: RAB14 activates MAPK signaling to promote bladder tumorigenesis.

Corrigendum: RAB14 activates MAPK signaling to promote bladder tumorigenesis.

Journal: Carcinogenesis
Published: June 14, 2019

MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.

MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.

Journal: OncoTargets and therapy
Published: December 27, 2018

Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.

Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.

Journal: Oncology letters
Published: November 03, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026